{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:50:11Z","timestamp":1791874211707,"version":"4.3.4"},"reference-count":150,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide belonging to the calcitonin family, discovered as a product of alternative splicing of the calcitonin gene. CGRP has emerged as a pleiotropic signaling molecule with widespread distribution in the central and peripheral nervous systems, particularly within primary sensory neurons. This narrative review synthesizes current knowledge on the CGRP system, integrating recent advances in its molecular structure, gene organization, and post-translational processing with high-resolution structural insights into its heterodimeric receptor complex (CLR-RAMP1) obtained through cryo-electron microscopy. We also include long-term safety data on anti-CGRP monoclonal antibodies, emerging cardiovascular risk signals, and novel therapeutic applications in vestibular migraine and pediatric populations. The intracellular signaling cascades activated by CGRP, including the canonical cAMP-PKA pathway, MAP kinase activation, and context-dependent calcium signaling, are discussed in relation to its diverse physiological functions. These encompass vasodilation, nociception modulation, neurogenic inflammation, gastrointestinal motility, bone metabolism, tissue regeneration, and energy homeostasis. The central role of CGRP in migraine pathophysiology is examined to understand the development of targeted therapies. The current pharmacological landscape is reviewed, including the evolution of small-molecule CGRP receptor antagonists (gepants) through three generations and the four approved monoclonal antibodies targeting CGRP or its receptor, with comparative analysis of their efficacy, safety profiles, and clinical positioning. Beyond migraine, emerging and predominantly preclinical roles of the CGRP system are discussed in chronic pain, osteoarthritis, cardiovascular diseases, sepsis, cancer (particularly bone metastases and tumor microenvironment immunomodulation), and neurodegenerative disorders such as Alzheimer\u2019s disease. In these areas, the available evidence remains heterogeneous and, in most cases, is not yet sufficient to support clinical translation. Finally, future directions are discussed, including the development of stable CGRP analogs, allosteric modulators, and the potential expansion of therapeutic applications into oncology, intensive care medicine, and neuroprotection.<\/jats:p>","DOI":"10.3390\/ijms27114973","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:45:08Z","timestamp":1780404308000},"page":"4973","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Calcitonin Gene-Related Peptide (CGRP): Biology, Signaling, Pathophysiological Roles, and Therapeutic Applications"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9379-203X","authenticated-orcid":false,"given":"Mar\u00eda Jes\u00fas","family":"Ram\u00edrez-Exp\u00f3sito","sequence":"first","affiliation":[{"name":"Experimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, School of Health Sciences, University of Ja\u00e9n, E23071 Ja\u00e9n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6149-090X","authenticated-orcid":false,"given":"Cristina","family":"Cueto-Ure\u00f1a","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, School of Health Sciences, University of Ja\u00e9n, E23071 Ja\u00e9n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2950-5614","authenticated-orcid":false,"given":"Jos\u00e9 Manuel","family":"Mart\u00ednez-Martos","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, School of Health Sciences, University of Ja\u00e9n, E23071 Ja\u00e9n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: Physiology and pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/298240a0","article-title":"Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products","volume":"298","author":"Amara","year":"1982","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/304129a0","article-title":"Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing","volume":"304","author":"Rosenfeld","year":"1983","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1007\/s10787-025-01848-1","article-title":"Neuroinflammatory crosstalk in migraine: Consolidated activity of rizatriptan and meloxicam in suppressing CGRP-induced nociception and COX-mediated inflammation","volume":"33","author":"Bhatia","year":"2025","journal-title":"Inflammopharmacology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1152\/physrev.00059.2021","article-title":"CGRP physiology, pharmacology, and therapeutic targets: Migraine and beyond","volume":"103","author":"Russo","year":"2023","journal-title":"Physiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s10194-023-01644-8","article-title":"Mode and site of action of therapies targeting CGRP signaling","volume":"24","author":"Caronna","year":"2023","journal-title":"J. Headache Pain"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ozge, A., Baykan, B., Bicakci, S., Ertas, M., Atalar, A.C., Gumru, S., and Karli, N. (2024). Revolutionizing migraine management: Advances and challenges in CGRP-targeted therapies and their clinical implications. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1402569"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/j.pain.0000000000000831","article-title":"The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine","volume":"158","author":"Iyengar","year":"2017","journal-title":"Pain"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ansari, S., and Aran, K.R. (2026). Modulating CGRP Signaling: A Promising Therapeutic Avenue for Attenuating Cardiac Dysfunction in Heart Failure. Cardiovasc. Drugs Ther.","DOI":"10.1007\/s10557-025-07830-x"},{"key":"ref_10","first-page":"572","article-title":"Calcitonin gene-related peptide (CGRP) in the pathophysiology of gastrointestinal disorders\u2014A key mediator in the gut-brain axis","volume":"117","author":"Crespo","year":"2025","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies\u2014Successful translation from bench to clinic","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-med-050224-111631","article-title":"CGRP and Migraine: Real-World Insights and Future Therapeutic Directions","volume":"77","author":"Russo","year":"2026","journal-title":"Annu. Rev. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11033-025-10542-y","article-title":"Unraveling the role of CGRP in neurological diseases: A comprehensive exploration to pathological mechanisms and therapeutic implications","volume":"52","author":"Sarkar","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"117206","DOI":"10.1016\/j.bcp.2025.117206","article-title":"Calcitonin gene-related peptide (CGRP): A potential therapeutic target against sepsis and sepsis-associated multiple organ failure","volume":"242","author":"Singh","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41586-018-0535-y","article-title":"Cryo-EM structure of the active, G(s)-protein complexed, human CGRP receptor","volume":"561","author":"Liang","year":"2018","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.trecan.2025.07.004","article-title":"CGRP-mediated neural addiction in tumor dynamic remodeling","volume":"11","author":"Xu","year":"2025","journal-title":"Trends Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00018-026-06090-8","article-title":"Temporal regulation of macrophage polarization by abnormally innervated CGRP + Sensory nerves following spinal cord injury","volume":"83","author":"Hu","year":"2026","journal-title":"Cell Mol. Life Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11916-025-01365-4","article-title":"Review: An Update on CGRP Monoclonal Antibodies for the Preventive Treatment of Episodic Migraine","volume":"29","author":"Nicol","year":"2025","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e214659","DOI":"10.1212\/WNL.0000000000214659","article-title":"Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort","volume":"106","author":"Caronna","year":"2026","journal-title":"Neurology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e70562","DOI":"10.1111\/ene.70562","article-title":"A Real-World Study of CGRP Monoclonal Antibodies for Migraine: Long-Term Effectiveness and Treatment Adherence","volume":"33","author":"Suzuki","year":"2026","journal-title":"Eur. J. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/head.70081","article-title":"Post-marketing safety of CGRP monoclonal antibodies and gepants: A systematic review of spontaneous reporting system data","volume":"66","author":"Giacon","year":"2026","journal-title":"Headache"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Xu, S., Song, W., Wang, Y., and Zhao, Y. (2026). Identifying cardiac safety signals of disproportionate reporting for CGRP antagonists: Evidence from the FDA Adverse Event Reporting System. Naunyn Schmiedebergs Arch. Pharmacol.","DOI":"10.1007\/s00210-026-05116-z"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e683","DOI":"10.1097\/MAO.0000000000004810","article-title":"Expression of Calcitonin Gene-related Peptide and Its Application to Cochlear Implantation Under Local Anesthesia With Monitored Anesthesia Care in the Very Elderly: The University of California, Los Angeles, Experience","volume":"47","author":"Xiao","year":"2026","journal-title":"Otol. Neurotol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"G73","DOI":"10.1152\/ajpgi.00230.2025","article-title":"Enteric glia, neuropeptides, and Parkinson\u2019s: Impacts of calcitonin gene-related peptide on gut alpha synuclein","volume":"330","author":"Templeton","year":"2026","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s10194-026-02283-5","article-title":"Effectiveness and safety of anti-CGRP monoclonal antibodies in hemiplegic migraine: An individual patient quantitative analysis","volume":"27","author":"Romozzi","year":"2026","journal-title":"J. Headache Pain"},{"key":"ref_26","unstructured":"Altmeyers, P. (2024). Calcitonin gene-related peptides. Altmeyers Encyclopedia\u2014Internal Medicine, EMG GmbH & Co. KG."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/341076a0","article-title":"Alternative production of calcitonin and CGRP mRNA is regulated at the calcitonin-specific splice acceptor","volume":"341","author":"Emeson","year":"1989","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/bi026753a","article-title":"SRp55 is a regulator of calcitonin\/CGRP alternative RNA splicing","volume":"42","author":"Tran","year":"2003","journal-title":"Biochemistry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0196-9781(97)00055-7","article-title":"Endoproteolysis at tetrabasic amino acid sites in procalcitonin gene-related peptide by pituitary cell lines","volume":"18","author":"Rosenblatt","year":"1997","journal-title":"Peptides"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/bph.12464","article-title":"Structure-activity relationships of the N-terminus of calcitonin gene-related peptide: Key roles of alanine-5 and threonine-6 in receptor activation","volume":"171","author":"Hay","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2017.01.006","article-title":"Large dense-core vesicle exocytosis from mouse dorsal root ganglion neurons is regulated by neuropeptide Y","volume":"346","author":"Bost","year":"2017","journal-title":"Neuroscience"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1242\/jcs.012211","article-title":"Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential","volume":"120","author":"Meng","year":"2007","journal-title":"J. Cell Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8523","DOI":"10.1073\/pnas.1203195109","article-title":"Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.molcel.2015.04.018","article-title":"Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor","volume":"58","author":"Booe","year":"2015","journal-title":"Mol. Cell"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kumar, A., Potts, J.D., and DiPette, D.J. (2019). Protective Role of alpha-Calcitonin Gene-Related Peptide in Cardiovascular Diseases. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.00821"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1021\/acs.jmedchem.5c03445","article-title":"Computational Design, Synthesis, and Evaluation of Stapled Peptide-Based Antagonists of the CGRP Receptor","volume":"69","author":"Schofield","year":"2026","journal-title":"J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/13892037113149990057","article-title":"Role of CGRP-receptor component protein (RCP) in CLR\/RAMP function","volume":"14","author":"Dickerson","year":"2013","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature22327","article-title":"Phase-plate cryo-EM structure of a class B GPCR\u2013G-protein complex","volume":"546","author":"Liang","year":"2018","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/acsptsci.9b00080","article-title":"Structure and Dynamics of Adrenomedullin Receptors AM(1) and AM(2) Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins","volume":"3","author":"Liang","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.bpj.2026.03.008","article-title":"Determinants of improved CGRP peptide binding kinetics revealed by enhanced molecular simulations","volume":"125","author":"Kilinc","year":"2026","journal-title":"Biophys. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1469-7793.1998.117bu.x","article-title":"ATP-sensitive K+ channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle","volume":"507","author":"Wellman","year":"1998","journal-title":"J. Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lfs.2015.11.015","article-title":"Calcitonin gene-related peptide mediates an inflammatory response in Schwann cells via cAMP-dependent ERK signaling cascade","volume":"144","author":"Permpoonputtana","year":"2016","journal-title":"Life Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3331024251364242","DOI":"10.1177\/03331024251364242","article-title":"PACAP versus CGRP in migraine: From mouse models to clinical translation","volume":"45","author":"Pietra","year":"2025","journal-title":"Cephalalgia"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"109541","DOI":"10.1016\/j.cellsig.2020.109541","article-title":"The road to ERK activation: Do neurons take alternate routes?","volume":"68","author":"Miningou","year":"2020","journal-title":"Cell. Signal."},{"key":"ref_45","first-page":"1007","article-title":"Calcitonin Gene-Related Peptide Regulates Cardiomyocyte Survival through Regulation of Oxidative Stress by PI3K\/Akt and MAPK Signaling Pathways","volume":"2","author":"Umoh","year":"2014","journal-title":"Ann. Clin. Exp. Hypertens."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7932","DOI":"10.1038\/s41598-019-44333-w","article-title":"CGRP signalling inhibits NO production through pannexin-1 channel activation in endothelial cells","volume":"9","author":"Gaete","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3331024251404478","DOI":"10.1177\/03331024251404478","article-title":"Indirect crosstalk between signalling pathways activated by CGRP and Piezo1 in human iPSC-derived endothelial cells relevant to migraine","volume":"45","author":"Gkouzioti","year":"2025","journal-title":"Cephalalgia"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/cyto.1998.0415","article-title":"Calcitonin gene-related peptide (CGRP) increases intracellular free Ca2+ concentrations but not cyclic AMP formation in CGRP receptor-positive osteosarcoma cells (OHS-4)","volume":"11","author":"Drissi","year":"1999","journal-title":"Cytokine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/head.15082","article-title":"TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms","volume":"66","author":"Reducha","year":"2026","journal-title":"Headache"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1021\/acsptsci.9b00089","article-title":"Distinct Patterns of Internalization of Different Calcitonin Gene-Related Peptide Receptors","volume":"3","author":"Gingell","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/FJC.0000000000000482","article-title":"G Protein-Coupled Receptor Signaling Through beta-Arrestin-Dependent Mechanisms","volume":"70","author":"Kaur","year":"2017","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-pharmtox-010814-124701","article-title":"Calcitonin gene-related peptide (CGRP): A new target for migraine","volume":"55","author":"Russo","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coph.2008.12.007","article-title":"CGRP receptors in the control of pain and inflammation","volume":"9","author":"Benemei","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/13892037113149990046","article-title":"Antiinflammatory activities of CGRP modulating innate immune responses in health and disease","volume":"14","author":"Holzmann","year":"2013","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00726-011-1161-2","article-title":"Modulation of immune responses by the neuropeptide CGRP","volume":"45","author":"Holzmann","year":"2013","journal-title":"Amino Acids"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Fouani, M., Kumari, S., Charles, A., Wickware, C., Moore, A.A., Cho, C.H., Abraham, S.N., and Moore, C.D. (2026). TRPV4-Mast Cell Interactions in Neurogenic Inflammation and Chronic Diseases: A Narrative Review. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27062865"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1600-0625.2011.01377.x","article-title":"Mast cell-derived TNF-alpha and histamine modify IL-6 and IL-8 expression and release from cutaneous tumor cells","volume":"20","author":"Artuc","year":"2011","journal-title":"Exp. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.molimm.2017.08.020","article-title":"Calcitonin gene-related peptide exerts anti-inflammatory property through regulating murine macrophages polarization in vitro","volume":"91","author":"Duan","year":"2017","journal-title":"Mol. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.neuron.2019.01.012","article-title":"A Mast-Cell-Specific Receptor Mediates Neurogenic Inflammation and Pain","volume":"101","author":"Green","year":"2019","journal-title":"Neuron"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1021\/acschembio.6b00616","article-title":"Neuropeptide-Induced Mast Cell Degranulation and Characterization of Signaling Modulation in Response to IgE Conditioning","volume":"11","author":"Manning","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Balcziak, L.K., and Russo, A.F. (2022). Dural Immune Cells, CGRP, and Migraine. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.874193"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Costa, R.F., Rosas, E.P., Paz, S.T., Freitas, M.F.L., Souza, S.L., Andrade, J.R., Oliveira, D.A., Jansen-Olesen, I., Christensen, S.L., and Valenca, M.M. (2024). Topiramate Inhibits Capsaicin-Induced Mast Cell Degranulation and CGRP Release in Rat Dura Mater. Brain Sci., 14.","DOI":"10.3390\/brainsci14111070"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10571-024-01456-7","article-title":"Expression of CGRP in the Trigeminal Ganglion and Its Effect on the Polarization of Macrophages in Rats with Temporomandibular Arthritis","volume":"44","author":"Tao","year":"2024","journal-title":"Cell Mol. Neurobiol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Holzer, P., and Holzer-Petsche, U. (2021). Constipation Caused by Anti-calcitonin Gene-Related Peptide Migraine Therapeutics Explained by Antagonism of Calcitonin Gene-Related Peptide\u2019s Motor-Stimulating and Prosecretory Function in the Intestine. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.820006"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.pedneo.2015.10.012","article-title":"Calcitonin Gene-Related Peptide Downregulates Expression of Inducible Nitride Oxide Synthase and Caspase-3 after Intestinal Ischemia-Reperfusion Injury in Rats","volume":"57","author":"Luo","year":"2016","journal-title":"Pediatr. Neonatol."},{"key":"ref_66","first-page":"933","article-title":"Role of calcitonin gene related peptide in the modulation of intestinal circulatory, metabolic, and myoelectric activity during ischemia\/reperfusion","volume":"51","author":"Pawlik","year":"2000","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.3892\/mmr.2016.5023","article-title":"CGRP may regulate bone metabolism through stimulating osteoblast differentiation and inhibiting osteoclast formation","volume":"13","author":"He","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jcp.22266","article-title":"Calcitonin gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by beta-catenin stabilization","volume":"225","author":"Mrak","year":"2010","journal-title":"J. Cell Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Li, H., Qu, J., Zhu, H., Wang, J., He, H., Xie, X., Wu, R., and Lu, Q. (2021). CGRP Regulates the Age-Related Switch Between Osteoblast and Adipocyte Differentiation. Front. Cell Dev. Biol., 9, Erratum in Front. Cell Dev. Biol. 2021, 9, 715740.","DOI":"10.3389\/fcell.2021.675503"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e22295","DOI":"10.1002\/advs.202522295","article-title":"CGRP Enhances the Regeneration of Bone Defects by Regulating Bone Marrow Mesenchymal Stem Cells Through Promoting ANGPTL4 Secretion by Bone Blood Vessels","volume":"13","author":"Lu","year":"2026","journal-title":"Adv. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"116258","DOI":"10.1016\/j.intimp.2026.116258","article-title":"IL-6 blockade at the fracture site accelerates bone healing via inflammatory modulation of sensory nerve CGRP signaling","volume":"173","author":"Sun","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12974-025-03483-7","article-title":"Pro-repair macrophages driven by CGRP rescue white matter integrity following intracerebral hemorrhage","volume":"22","author":"Huang","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/ten.tea.2020.0009","article-title":"Calcitonin Gene-Related Peptide Enhances Distraction Osteogenesis by Increasing Angiogenesis","volume":"27","author":"Mi","year":"2021","journal-title":"Tissue Eng. Part. A"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.biopha.2008.02.003","article-title":"Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis","volume":"62","author":"Toda","year":"2008","journal-title":"Biomed. Pharmacother."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1096\/fj.13-238998","article-title":"Roles of receptor activity-modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice","volume":"28","author":"Kurashige","year":"2014","journal-title":"FASEB J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41586-024-07237-y","article-title":"CGRP sensory neurons promote tissue healing via neutrophils and macrophages","volume":"628","author":"Lu","year":"2024","journal-title":"Nature"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"103015","DOI":"10.1016\/j.mtbio.2026.103015","article-title":"Sustained-release CGRP microspheres accelerate diabetic wound healing by synergistically promoting neurovascular regeneration through modulation of macrophage and endothelial cell functions","volume":"37","author":"Zhao","year":"2026","journal-title":"Mater. Today Bio"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/s41598-024-52029-z","article-title":"Calcitonin gene-related peptide regulates periodontal tissue regeneration","volume":"14","author":"Miki","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"110608","DOI":"10.1016\/j.intimp.2023.110608","article-title":"Calcitonin Gene-Related peptide receptor antagonist suppresses allergic asthma responses via downregulation of group 2 innate lymphoid cells in mice","volume":"122","author":"Ike","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Li, M., Wetzel-Strong, S.E., Hua, X., Tilley, S.L., Oswald, E., Krummel, M.F., and Caron, K.M. (2014). Deficiency of RAMP1 attenuates antigen-induced airway hyperresponsiveness in mice. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102356"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"eaan8546","DOI":"10.1126\/science.aan8546","article-title":"Pulmonary neuroendocrine cells amplify allergic asthma responses","volume":"360","author":"Sui","year":"2018","journal-title":"Science"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1365-2222.2011.03822.x","article-title":"The neuropeptide calcitonin gene-related peptide affects allergic airway inflammation by modulating dendritic cell function","volume":"41","author":"Rochlitzer","year":"2011","journal-title":"Clin. Exp. Allergy"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Bonura, A., Brunelli, N., Marcosano, M., Iaccarino, G., Fofi, L., Vernieri, F., and Altamura, C. (2023). Calcitonin Gene-Related Peptide Systemic Effects: Embracing the Complexity of Its Biological Roles-A Narrative Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241813979"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Braasch, D.C., Deegan, E.M., Grimm, E.R., and Griffin, J.D. (2008). Calcitonin gene-related peptide alters the firing rates of hypothalamic temperature sensitive and insensitive neurons. BMC Neurosci., 9.","DOI":"10.1186\/1471-2202-9-64"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"101161","DOI":"10.1016\/j.molmet.2021.101161","article-title":"Sensory neurons expressing calcitonin gene-related peptide alpha regulate adaptive thermogenesis and diet-induced obesity","volume":"45","author":"Makwana","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/23328940.2015.1102802","article-title":"Central mediators involved in the febrile response: Effects of antipyretic drugs","volume":"2","author":"Zampronio","year":"2015","journal-title":"Temperature"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.maturitas.2009.08.011","article-title":"Calcitonin gene-related peptide, adrenomedullin and flushing","volume":"64","author":"Hay","year":"2009","journal-title":"Maturitas"},{"key":"ref_88","first-page":"5","article-title":"Calcitonin gene-related peptide and menopause","volume":"1","author":"Sharma","year":"2010","journal-title":"J. Midlife Health"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S0022-5347(05)65660-1","article-title":"Momentary increase in plasma calcitonin gene-related peptide is involved in hot flashes in men treated with castration for carcinoma of the prostate","volume":"166","author":"Spetz","year":"2001","journal-title":"J. Urol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Al-Karagholi, M.A., Kalatharan, V., Fagerberg, P.S., and Amin, F.M. (2023). The vascular role of CGRP: A systematic review of human studies. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1204734"},{"key":"ref_91","first-page":"579321","article-title":"Acupuncture as treatment of hot flashes and the possible role of calcitonin gene-related Peptide","volume":"2012","author":"Frisk","year":"2012","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Wilhelms, D.B., Dock, H., Brito, H.O., Pettersson, E., Stojakovic, A., Zajdel, J., Engblom, D., Theodorsson, E., Hammar, M.L., and Spetz Holm, A.E. (2018). CGRP Is Critical for Hot Flushes in Ovariectomized Mice. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01452"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e214479","DOI":"10.1212\/WNL.0000000000214479","article-title":"Calcitonin Gene-Related Peptide Inhibitors and Cardiovascular Events in Patients With Migraine: A Retrospective, Observational Cohort Study","volume":"106","author":"Lusk","year":"2026","journal-title":"Neurology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3331024241297673","DOI":"10.1177\/03331024241297673","article-title":"Impact of CGRP monoclonal antibody treatment on blood pressure in patients with migraine: A systematic review and potential clinical implications","volume":"45","author":"Olsen","year":"2025","journal-title":"Cephalalgia"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s10194-025-02043-x","article-title":"Unmasking the relationship between CGRP and glutamate: From peripheral excitation to central sensitization in migraine","volume":"26","author":"Martami","year":"2025","journal-title":"J. Headache Pain"},{"key":"ref_96","first-page":"1","article-title":"Anti-CGRP monoclonal antibodies for chronic migraine with medication-overuse headache: A conservative meta-analysis","volume":"84","author":"Makita","year":"2026","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"100060","DOI":"10.1016\/j.metop.2020.100060","article-title":"Monoclonal therapy against calcitonin gene-related peptide lowers hyperglycemia and adiposity in type 2 diabetes mouse models","volume":"8","author":"Halloran","year":"2020","journal-title":"Metabol. Open"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/en.2016-1510","article-title":"Endogenous Calcitonin Gene-Related Peptide Regulates Lipid Metabolism and Energy Homeostasis in Male Mice","volume":"158","author":"Liu","year":"2017","journal-title":"Endocrinology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12020-017-1404-4","article-title":"Role of calcitonin gene-related peptide in energy metabolism","volume":"58","author":"Lima","year":"2017","journal-title":"Endocrine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1210\/en.2010-0284","article-title":"Mice lacking the neuropeptide alpha-calcitonin gene-related peptide are protected against diet-induced obesity","volume":"151","author":"Walker","year":"2010","journal-title":"Endocrinology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","article-title":"Migraine and the trigeminovascular system-40 years and counting","volume":"18","author":"Ashina","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","article-title":"Migraine: Disease characterisation, biomarkers, and precision medicine","volume":"397","author":"Ashina","year":"2021","journal-title":"Lancet"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/head.14903","article-title":"Pharmacological differences and switching among anti-CGRP monoclonal antibodies: A narrative review","volume":"65","author":"Romozzi","year":"2025","journal-title":"Headache"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41582-019-0216-y","article-title":"Does inflammation have a role in migraine?","volume":"15","author":"Edvinsson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1091\/mbc.e10-01-0049","article-title":"Acid activation of Trpv1 leads to an up-regulation of calcitonin gene-related peptide expression in dorsal root ganglion neurons via the CaMK-CREB cascade: A potential mechanism of inflammatory pain","volume":"21","author":"Nakanishi","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/ohn.70196","article-title":"Early Experience Treating Vestibular Migraine With Small Molecule CGRP Antagonists","volume":"174","author":"Patel","year":"2026","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/head.15075","article-title":"Calcitonin gene-related peptide in the audiovestibular system","volume":"66","author":"Patel","year":"2026","journal-title":"Headache"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/JCMA.0000000000001351","article-title":"Potential therapeutic role of calcitonin gene-related peptide medications for tinnitus","volume":"89","author":"Dichter","year":"2026","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Mattar, M., Umutoni, F., Hassan, M.A., Wamburu, M.W., Turner, R., Patton, J.S., Chen, X., and Lei, W. (2024). Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment. Life, 14.","DOI":"10.3390\/life14080991"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"17448069251314857","DOI":"10.1177\/17448069251314857","article-title":"Upregulation of the neuropeptide receptor calcitonin receptor-like in the spinal cord via MLL2 in a mouse model of paclitaxel-induced peripheral neuropathy","volume":"21","author":"Sierra","year":"2025","journal-title":"Mol. Pain"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"17448069261432028","DOI":"10.1177\/17448069261432028","article-title":"CGRP expression and signaling sensitization in a mouse model of chronic oxaliplatin-induced peripheral neuropathy","volume":"22","author":"Du","year":"2026","journal-title":"Mol. Pain"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/bcp.12669","article-title":"Calcitonin gene-related peptide in the joint: Contributions to pain and inflammation","volume":"80","author":"Walsh","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.joca.2018.08.019","article-title":"CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial","volume":"26","author":"Jin","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"13550","DOI":"10.1073\/pnas.0800767105","article-title":"Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide","volume":"105","author":"Toda","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e202302041","DOI":"10.26508\/lsa.202302041","article-title":"Crosstalk between bone metastatic cancer cells and sensory nerves in bone metastatic progression","volume":"7","author":"Park","year":"2024","journal-title":"Life Sci. Alliance"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"116994","DOI":"10.1016\/j.celrep.2026.116994","article-title":"CGRP signaling links tumor-associated pain to immune evasion in oral squamous cell carcinoma","volume":"45","author":"McIlvried","year":"2026","journal-title":"Cell Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e214584","DOI":"10.1212\/WNL.0000000000214584","article-title":"Heart of the Matter: Calcitonin Gene-Related Peptide Antagonists and Cardiovascular Risk","volume":"106","author":"Terman","year":"2026","journal-title":"Neurology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"116080","DOI":"10.1016\/j.intimp.2025.116080","article-title":"CGRP alleviates epilepsy via JAK1-STAT1-P2RX7 signaling: A novel neuroprotective axis targeting neuronal damage","volume":"170","author":"Li","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clim.2017.06.002","article-title":"TCR+CD3+CD4\u2212CD8\u2212 effector T cells in psoriasis","volume":"181","author":"Brandt","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Kamata, M., and Tada, Y. (2023). Crosstalk: Keratinocytes and immune cells in psoriasis. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1286344"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Honryo, A., Masuda, T., Nakamizo, S., Takafuji, T., Minami, F., Yonekura, S., Uchibayashi, M., Inoue, K., Kiyonari, H., and Yamanaka, M. (2026). IL-31 blockade elevates thymus and activation-regulated chemokine by lifting LAMP3+CD1c+ mature dendritic cells from calcitonin gene-related peptide-calcitonin receptor-like neuroimmune suppression in atopic dermatitis. J. Allergy Clin. Immunol.","DOI":"10.1016\/j.jaci.2026.02.044"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e70177","DOI":"10.1002\/ejp.70177","article-title":"Calcitonin Gene-Related Peptide (CGRP) Levels of Children and Adolescents With Migraine: A Systematic Review and Meta-Analysis of Observational Studies","volume":"30","author":"Zhu","year":"2026","journal-title":"Eur. J. Pain"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Jakubowska, B., and Sowa-Kucma, M. (2025). Gepants: Targeting the CGRP pathway for migraine relief. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1708226"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40263-025-01233-0","article-title":"Estimating Changes in Clinical Outcomes after Discontinuation of Anti-CGRP Targeting Therapy for Migraine Prophylaxis: A Systematic Review and Meta-analysis","volume":"40","author":"Makita","year":"2026","journal-title":"CNS Drugs"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/head.70057","article-title":"Evaluating dual calcitonin gene-related peptide antagonists for chronic migraine prevention","volume":"66","author":"Graves","year":"2026","journal-title":"Headache"},{"key":"ref_126","first-page":"75","article-title":"Real-World Insights into Dual Calcitonin Gene-Related Peptide (CGRP) Therapies for Chronic Migraine: A Retrospective Review","volume":"29","author":"Lee","year":"2026","journal-title":"Pain Physician"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"6907","DOI":"10.1007\/s10072-025-08484-1","article-title":"Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: Third interim analysis of the pan-European PEARL study","volume":"46","author":"Ashina","year":"2025","journal-title":"Neurol. Sci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s40122-026-00839-6","article-title":"Results from TRIUMPH [EUROPE], a Real-World Observational Study on the 3-Month Effectiveness of Galcanezumab Versus Traditional Oral Migraine Preventive Medications","volume":"15","author":"Tassorelli","year":"2026","journal-title":"Pain Ther."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Uberall, M.A. (2026). PRIME-Teen-Treatment Persistence and Outcomes Associated with CGRP Monoclonal Antibodies Compared with Conventional Oral Preventives in Adolescents with High-Burden Migraine: An Exploratory Real-World Analysis from the German Pain e-Registry (GPeR). J. Clin. Med., 15.","DOI":"10.3390\/jcm15051976"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Uberall, M.A., Muller-Schwefe, P.C.G., Kuster, M.A., and Jansen, J.P. (2026). Treatment Persistence in Migraine Prophylaxis Comparing CGRP Monoclonal Antibodies vs. High-\/Low-Evidence Conventional Oral Preventives-A Comparative Real-World Evidence Study of Depersonalized Data of the German Pain e-Registry. J. Clin. Med., 15.","DOI":"10.3390\/jcm15051985"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/08830738251374537","article-title":"The Use of Anti-CGRP Medications for Management of Intractable Chronic Daily Headaches in the Pediatric Population: Case Series and Literature Review","volume":"41","author":"Akbar","year":"2026","journal-title":"J. Child. Neurol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12883-026-04733-8","article-title":"Safety and efficacy of calcitonin gene-related peptide antagonists for cluster headache: A systematic review and meta-analysis","volume":"26","author":"Khanfar","year":"2026","journal-title":"BMC Neurol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"3331024261434209","DOI":"10.1177\/03331024261434209","article-title":"Efficacy and effectiveness of anti-CGRP monoclonal antibodies treatment in the prevention of cluster headache attacks: A systematic review and meta-analysis","volume":"46","author":"Kolakowski","year":"2026","journal-title":"Cephalalgia"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13005-025-00494-w","article-title":"Unveiling the efficacy and safety of Erenumab, a monoclonal antibody targeting calcitonin gene-related peptide (CGRP) receptor, in patients with chronic and episodic migraine: A GRADE-assessed systematic review and meta-analysis of randomized clinical trials with subgroup analysis","volume":"21","author":"Haseeb","year":"2025","journal-title":"Head. Face Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00228-025-03934-3","article-title":"Efficacy and safety of CGRP monoclonal antibodies for migraine prevention in episodic migraine; a network Meta-analysis","volume":"82","author":"Shakir","year":"2026","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Scuteri, D., and Martelletti, P. (2025). Translational Impact of Genetics and Epigenetics of CGRP System on Chronic Migraine Treatment with Onabotulinumtoxin A and Other Biotech Drugs. Toxins, 17.","DOI":"10.3390\/toxins17070355"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s10194-025-02040-0","article-title":"Increased infection risk in patients on preventive CGRP-targeting therapies- a meta-analysis and clinical effect assessment","volume":"26","author":"Straburzynski","year":"2025","journal-title":"J. Headache Pain"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMoa2035908","article-title":"Atogepant for the Preventive Treatment of Migraine","volume":"385","author":"Ailani","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/head.70082","article-title":"Delayed urticaria during treatment with anti-CGRP monoclonal antibodies in migraine","volume":"66","author":"Berger","year":"2026","journal-title":"Headache"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e213852","DOI":"10.1212\/WNL.0000000000213852","article-title":"CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke: A Review","volume":"105","author":"Eller","year":"2025","journal-title":"Neurology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e70481","DOI":"10.1111\/ene.70481","article-title":"Letter to the Editor: Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy","volume":"33","author":"Gaul","year":"2026","journal-title":"Eur. J. Neurol."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Polanco, M., Gonzalez-Quintanilla, V., Madera, J., Perez-Pereda, S., Garate, G., and Pascual, J. (2026). Switching strategies with CGRP monoclonal antibodies: An observational study in a headache clinic. Front. Neurol., 17, Correction in Front. Neurol. 2026, 17, 1845315.","DOI":"10.3389\/fneur.2026.1845315"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/S0140-6736(18)32534-0","article-title":"Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: A randomised, double-blind, placebo-controlled, phase 3b study","volume":"392","author":"Reuter","year":"2018","journal-title":"Lancet"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14737175.2025.2596783","article-title":"Medication-overuse headache: Can anti-CGRP monoclonal antibodies replace withdrawal?","volume":"26","author":"Pellesi","year":"2026","journal-title":"Expert. Rev. Neurother."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11325-025-03563-1","article-title":"OSA screening before CGRP mAbs in chronic migraine","volume":"30","author":"Soomro","year":"2026","journal-title":"Sleep. Breath."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/head.70012","article-title":"False nonresponders to anti-calcitonin gene-related peptide monoclonal antibodies: A real-world analysis beyond migraine frequency reduction","volume":"66","author":"Termens","year":"2026","journal-title":"Headache"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3331024251413488","DOI":"10.1177\/03331024251413488","article-title":"2025 Highlights in new targets for migraine treatment","volume":"46","author":"Haanes","year":"2026","journal-title":"Cephalalgia"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"3331024251411865","DOI":"10.1177\/03331024251411865","article-title":"2025 Highlights in migraine prevention","volume":"46","author":"Ornello","year":"2026","journal-title":"Cephalalgia"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Garcia-Castillo, M.C., Sierra-Mencia, A., Caronna, E., Toledo-Alfocea, D., Jaimes, A., Urtiaga, S., Casas-Limon, J., Munoz-Vendrell, A., Santos-Lasaosa, S., and Garcia Martin, V. (2026). Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study. Headache.","DOI":"10.1111\/head.70086"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"118361","DOI":"10.1016\/j.ejmech.2025.118361","article-title":"Structure-guided rational design of dual-target CGRP antagonist\/5HT1F agonist therapeutics for migraine","volume":"302","author":"Zou","year":"2026","journal-title":"Eur. J. Med. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4973\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:01:50Z","timestamp":1780405310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":150,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27114973"],"URL":"https:\/\/doi.org\/10.3390\/ijms27114973","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]}}}